UK's Oxford Nanopore rises after forecasting strong annual revenue growth
** Shares of British biotech firm Oxford Nanopore ONT.L up 5.31% at 140.535 p, among top gainers on London's mid-caps index .FTMC ** Co expects 2025 constant revenue growth to be at the top end of its previously stated guidance range of 20%-23% ** ONT says all other financial metrics tracking in line with expectations ** Up to Thursday's close, stock had risen 3.8% (Reporting by Simone Lobo) ((Simone.Lobo@thomsonreuters.com, +919920570373))
Recent news on Oxford Nanopore Technologies
See all newsBrief: Oxford Nanopore Technologies Says Nick Keher, CFO, To Assume Additional Responsibilities From July 1, 2026
Oxford Nanopore Tech - Changes to Director Roles and Responsibilities
UK's IP Group rebuffs top investor Railpen's $810 million takeover proposal
Brief: Railways Pension Trustee Company Limited Announces Possible Offer For All IP Group Shares
Oxford Nanopore Tech - Share Incentive Plan - Director/PDMR Shareholding